Jia Jie (Taiwan) Performance
| 4109 Stock | TWD 24.00 0.20 0.84% |
The company retains a Market Volatility (i.e., Beta) of 0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Jia Jie's returns are expected to increase less than the market. However, during the bear market, the loss of holding Jia Jie is expected to be smaller as well. At this point, Jia Jie Biomedical has a negative expected return of -0.37%. Please make sure to check out Jia Jie's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Jia Jie Biomedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Jia Jie Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 344.2 M | |
| Total Cashflows From Investing Activities | -173 M | |
| Free Cash Flow | 2.9 M |
Jia |
Jia Jie Relative Risk vs. Return Landscape
If you would invest 3,065 in Jia Jie Biomedical on September 1, 2024 and sell it today you would lose (665.00) from holding Jia Jie Biomedical or give up 21.7% of portfolio value over 90 days. Jia Jie Biomedical is generating negative expected returns and assumes 1.7818% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Jia, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jia Jie Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jia Jie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jia Jie Biomedical, and traders can use it to determine the average amount a Jia Jie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2087
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4109 |
Estimated Market Risk
| 1.78 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Jia Jie is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jia Jie by adding Jia Jie to a well-diversified portfolio.
Jia Jie Fundamentals Growth
Jia Stock prices reflect investors' perceptions of the future prospects and financial health of Jia Jie, and Jia Jie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jia Stock performance.
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.0021 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 88.94 M | |||
| Price To Earning | 531.58 X | |||
| Price To Book | 1.42 X | |||
| Price To Sales | 4.22 X | |||
| Revenue | 242.48 M | |||
| EBITDA | 18.79 M | |||
| Cash And Equivalents | 141.1 M | |||
| Cash Per Share | 2.05 X | |||
| Total Debt | 190.33 M | |||
| Debt To Equity | 27.10 % | |||
| Book Value Per Share | 10.08 X | |||
| Cash Flow From Operations | 4.37 M | |||
| Earnings Per Share | 0.08 X | |||
| Total Asset | 1.02 B | |||
About Jia Jie Performance
Evaluating Jia Jie's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Jia Jie has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jia Jie has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Jia Jie Biomedical Co., Ltd. provides natural terrapin related nutrition supplements in Taiwan, Japan, and Mainland China. Jia Jie Biomedical Co., Ltd. was founded in 1995 and is based in Kaohsiung, Taiwan. MURAD CHIA is traded on Taiwan OTC Exchange in Taiwan.Things to note about Jia Jie Biomedical performance evaluation
Checking the ongoing alerts about Jia Jie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jia Jie Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jia Jie Biomedical generated a negative expected return over the last 90 days | |
| About 42.0% of the company shares are owned by insiders or employees |
- Analyzing Jia Jie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jia Jie's stock is overvalued or undervalued compared to its peers.
- Examining Jia Jie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jia Jie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jia Jie's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jia Jie's stock. These opinions can provide insight into Jia Jie's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Jia Stock Analysis
When running Jia Jie's price analysis, check to measure Jia Jie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jia Jie is operating at the current time. Most of Jia Jie's value examination focuses on studying past and present price action to predict the probability of Jia Jie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jia Jie's price. Additionally, you may evaluate how the addition of Jia Jie to your portfolios can decrease your overall portfolio volatility.